Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands

Europace

Volumn 20, Issue 1, 2018, Pages 12-18

  Jacobs, Maartje S ^a,b   Kaasenbrood, Femke ^c   Postma, Maarten J ^b,d   Van Hulst, Marinus ^a,b   Tieleman, Robert G ^a,d  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atrial fibrillation; Cost effectiveness; Health economic modelling; Primary care; Screening; Single lead ECG; Stroke prevention

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION TREE; EARLY DIAGNOSIS; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MARKOV CHAIN; NETHERLANDS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SEASONAL INFLUENZA; SENSITIVITY ANALYSIS; CLINICAL DECISION MAKING; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DEVICES; ECONOMIC MODEL; ECONOMICS; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE COST; MALE; MASS SCREENING; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIMARY HEALTH CARE; REPRODUCIBILITY; VACCINATION;

INFLUENZA VACCINE;

AGED; ATRIAL FIBRILLATION; CLINICAL DECISION-MAKING; COMPUTER SIMULATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE COSTS; HUMANS; INFLUENZA VACCINES; MALE; MARKOV CHAINS; MASS SCREENING; MODELS, ECONOMIC; NETHERLANDS; POINT-OF-CARE TESTING; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; STROKE; VACCINATION;

EID: 85040794386     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euw285     Document Type: Article

References (20)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser S, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace 2012;14:1385-413.
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-73.
3. Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011;342:d124.
4. Friberg L, Rosenqvist M, Lindgren A, Terent A, Norrving B, Asplund K. High prevalence of atrial fibrillation among patients with stroke. Stroke 2014;45:2599-605.
5. Pisters R, van Oostenbrugge RJ, Knottnerus IL, de Vos CB, Boreas A, Lodder J, et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010;12:779-84.
6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
7. Flaker GC, Belwe K, Beckamn K, Vidaillet H, Kron J, Safford R, et al. Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63.
8. Potpara TS, Polovina MM, Marinkovic JM, Lip GY. Comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: The Belgrade Atrial Fibrillation Study. Int J Cardiol 2013;168:4744-9.
9. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146: 857-67.
10. Sharma M, Cornelius V, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: Systematic review and meta-analysis. Circulation 2015;132:194-204.
11. Tacken MA, Jansen B, Mulder J, Tiersma W, Braspenning J. Monitoring vaccination coverage national program influenza prevention 2013. Nijmegen: IQ Healthcare; 2014. http://www.rivm.nl (5 February 2015, date last accessed).
12. Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead ECG device during influenza vaccination. Europace 2016;18: 1514-20.
13. Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014;16:1291-5.
14. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: Cluster randomised controlled trial. BMJ 2007;335:383.
15. Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, et al. Costeffectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace 2015;17:1023-9.
16. Hobbs FDR, Fitzmaurice DA, Jowett S, Mant J, Murray E, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9:1-72.
17. Oortwijn WJ. Naar een rechtvaardige verdeling van de collectieve middelen: Barriè res en mogelijkheden. Zicht op zinnige en duurzame zorg. Raad voor Volksgezondheid en Zorg, 2006. www.raadrvs.nl (30 March 2016, date last accessed).
18. Desteghe L, Raymaekers Z, Lutin M, Vijgen J, Dilling-Boer D, Koopman P, et al. Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting. Europace 2017;19: 29-39.
19. Levin LA, Husberg M, Sobocinski PD, Frykman Kull V, Friberg L, Rosenqvist M, et al. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Europace 2015;17:207-14.
20. Xiong Q, Proietti M, Senoo K, Lip GY. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. Int J Cardiol 2015;191:172-7.